Trial Profile
Phase II prospective study with BAY-43-9006 in advanced, metastatic soft tissue sarcomas, after anthracycline-based therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jun 2011
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Sarcoma
- Focus Therapeutic Use
- 01 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Aug 2008 Planned end date (Sep 2010) added as reported by ClinicalTrials.gov
- 12 Dec 2006 New trial record.